
Dynacor Group Declares August 2025 Dividend
The Corporation's monthly dividend qualifies as an 'eligible dividend' for Canadian income tax purposes. The payment and increase of dividends are at the discretion of the Board and will depend on the Corporation's financial results, cash requirements, prospects and other factors deemed relevant by the Board.
About Dynacor
Dynacor Group is an industrial ore processing company dedicated to producing gold sourced from artisanal miners. Since its establishment in 1996, Dynacor has pioneered a responsible mineral supply chain with stringent traceability and audit standards for the fast-growing artisanal mining industry. By focusing on fully and part-formalized miners, the Canadian company offers a win-win approach for governments and miners globally. Dynacor operates the Veta Dorada plant and owns a gold exploration property in Peru. The company is planning to expand to West Africa and within Latin America.
The premium paid by luxury jewellers for Dynacor's PX Impact® gold goes to Fidamar Foundation, an NGO that mainly invests in health and education projects for artisanal mining communities in Peru. Visit
www.dynacor.com
for more information.
Forward-Looking Information
Certain statements in the preceding may constitute forward-looking statements, which involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Dynacor, or industry results, to be materially different from any future result, performance or achievement expressed or implied by such forward-looking statements. These statements reflect management's current expectations regarding future events and operating performance as of the date of this news release.
Contact:
For more information, please contact:
Ruth Hanna
Director, Investor Relations
T: 514-393-9000 #236
E:
investors@dynacor.com
Website:
https://dynacor.com
Renmark Financial Communications Inc.
Bettina Filippone
T: (416) 644-2020 or (212) 812-7680
E:
bfilippone@renmarkfinancial.com
Website:
www.renmarkfinancial.com

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Yahoo
31 minutes ago
- Yahoo
Bell Canada and Cohere strike AI partnership to bolster domestic data sovereignty
-- BCE (NYSE:BCE) Inc (TSX:BCE) and Toronto-based AI firm Cohere have announced a strategic partnership aimed at delivering sovereign, enterprise-grade AI solutions to Canadian governments and businesses. Under the agreement, Bell Canada will serve as Cohere's preferred infrastructure provider in Canada, while Cohere becomes Bell's go-to supplier for large language models (LLMs) and agentic AI platforms. Cohere's AI capabilities, including its North agentic AI platform, will now be integrated into Bell AI Fabric, a multi-layered ecosystem comprising data centres, fibre infrastructure, cloud software, and AI applications. The partnership enables Canadian organizations to access state-of-the-art AI tools without compromising data sovereignty or security. "At a critical time for Canada, we're proud to partner with Cohere to create a sovereign, full-stack AI solution, custom-built to support Canadian government and business," said Mirko Bibic, President and CEO of Bell Canada. "Working together, we will both transform Canadian businesses through cutting edge AI capabilities, while ensuring that the data remains secure and within Canada." North, Cohere's agentic AI development platform, will be made available across Bell's enterprise and government customer base, enabling efficient deployment of custom AI agents. The platform is designed to preserve Canadian data privacy standards while eliminating the need for customers to manage complex AI infrastructure. Cohere co-founder and CEO Aidan Gomez called the collaboration a significant step for Canadian AI adoption. 'Our partnership with Bell Canada will provide the Canadian government and enterprises with world-class options for sovereign, security-first AI,' he said. 'This has the potential to be truly transformative for organizations looking to massively increase their productivity and efficiency without any compromise on data security and privacy.' Bell plans to integrate North internally to empower employees in building AI agents that utilize proprietary data for operational improvements. Lessons learned internally will inform Bell's tech services brand, Ateko, as it aids customers in their AI deployments. The government's endorsement further signals growing confidence in domestic AI capabilities. 'These companies exemplify the spirit of Canadian ingenuity and are solidifying Canada's sovereign AI capabilities,' said Evan Solomon, Minister of Artificial Intelligence and Digital Innovation. 'This partnership will help strengthen our position on the global stage and pave the way for a brighter, more advanced future for the Canadian economy.' Related articles Bell Canada and Cohere strike AI partnership to bolster domestic data sovereignty Risks Rising? Smart Money Dodged 46%+ Drawdowns on These High-Flying Names If Powell goes, does Fed trust go with him?
Yahoo
an hour ago
- Yahoo
EDF power solutions North America Names Amy Lloyd as Chief Financial Officer
SAN DIEGO, July 28, 2025--(BUSINESS WIRE)--EDF power solutions North America is pleased to announce the appointment of Amy Lloyd as Chief Financial Officer (CFO). With an exceptional background in finance, investment, and infrastructure, Amy is a valuable addition to the executive team as the company continues its commitment to driving sustainable energy solutions across North America. Amy brings over two decades of experience in key leadership roles at global organizations, including Barclays, Citigroup Capital Markets, and ACS Infrastructure Development. Her extensive background encompasses originating and executing large-scale structured projects in infrastructure, energy, and real estate, with a focus on green energy and climate-focused financing. Notably, she has been instrumental in advising, lending, and raising over $25 billion in private financing for more than 20 large infrastructure projects worldwide. During her tenure at Barclays, and previously Citigroup, Amy excelled as a financial advisor, strategic M&A banker, and underwriter, delivering innovative financing solutions to public and private clients. Her accomplishments include advising on large-scale M&A, capital raises for battery manufacturing, hyperscale and data center financing, solar energy advisory, and financing sustainable materials manufacturers. Prior to joining Barclays, she held the position of Chief Financial Officer & Head of Finance at ACS Infrastructure Development, where she led strategic equity and finance initiatives, deploying over $5 billion in equity and debt capital across the U.S. and Canadian infrastructure markets. "Amy's comprehensive expertise in project finance, M&A, risk management, and asset optimization, combined with her proven leadership in corporate finance, will be invaluable as we continue to expand our low-carbon energy initiatives," said Tristan Grimbert, President and CEO of EDF power solutions North America. "Her innovative approach to financial strategy and commitment to sustainability align perfectly with EDF power solutions' mission to lead the transition to a sustainable energy future. We are excited to welcome her to our team and look forward to her contributions in advancing our mission." Amy holds a Master of Applied Finance from Macquarie University and dual bachelor's degrees in mathematics and politics from the University of Wollongong, Australia. Her global experience across Australia, North America, Europe, the UK, and the Middle East further enhances her ability to navigate complex financial landscapes and foster strategic partnerships. EDF power solutions North America has been providing clean energy solutions throughout the U.S., Canada, and Mexico since 1987. We are a market-leading independent power producer and service provider, serving utilities, corporations, industries, communities, institutions, and investors with reliable, low-carbon energy solutions that help meet growing demand. From developing and building scalable wind (onshore and offshore), solar, storage (battery and pumped storage hydropower), smart EV charging, microgrids, green hydrogen, and transmission projects to maximizing performance and profitability through skilled operations and maintenance and innovative asset optimization, our teams deliver expert solutions along the entire value chain—from origination to commercial operation. Our portfolio consists of 23 gigawatts of developed projects and 16 gigawatts under service contracts. In Canada, the Company has 2.6 GW of wind and solar power facilities in service or under construction. EDF power solutions is an affiliate of the EDF Group, a world leader in power production. For more information visit: Connect with us on LinkedIn, Instagram, and Facebook. View source version on Contacts EDF power solutions North America Sandi Brinermediarelations@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Business Wire
an hour ago
- Business Wire
Mauna Kea Technologies Reports First Half 2025 Revenue
PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News: Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced its revenue for the first half and the first two quarters of 2025, ended June 30, 2025. First Half of 2025 Performance Summary Total revenue for the first half of 2025 amounted to €3.7m, representing a slight decline of 5% compared to H1 2024. U.S. revenue for the first half of 2025 grew by +14% as reported and +17% in constant currency, with a significant dollar depreciation against the euro, especially in Q2 2025. U.S. operations remained robust, with accelerated growth in Q2 2025: sales rose +23% at constant currency vs. Q2 2024, and up +11% in Q1 2025 vs. Q1 2024, boosted by the expansion of the sales team. Growth in the U.S. was primarily driven by system and probe sales, particularly in the pancreatic cysts indication, more than offsetting a decline in PPU revenue due to the gradual impact of lower Medicare reimbursement rates starting in 2024. In Europe, business activity was gradually impacted by the Company's financial context. However, this decline was almost entirely offset by strong performances in other regions. Sacha Loiseau, Ph.D., Chairman and CEO of Mauna Kea Technologies, stated: 'This first half confirms the relevance of our strategic decisions in our primary market, the United States, where we are seeing continued and sustained sales growth. This momentum is all the more noteworthy given that it was achieved with a reduced sales force, reflecting a strong increase in sales productivity per representative, now at a record level of over $900K, compared to just $200K in 2021. W e are also observing increased usage of Cellvizio and growing interest from new centers, particularly for indications such as pancreatic cysts and food intolerances. Pay-per-use procedure volumes have remained stable at over 800 per quarter for the past year, despite the reduction in Medicare reimbursement. The signing of three new hospitals at the end of H1 gives us confidence in a rebound in volumes going forward. I n Europe and the rest of the world, where our approach remains more opportunistic due to the lack of reimbursement, our activity was impacted by the financial environment. We are currently restructuring the organization to quickly improve efficiency in the coming months, including geographic expansion into high-potential markets such as Australia, which we recently announced. T he financial situation currently faced by Mauna Kea has, of course, had an impact on the Company's operations. However, the slight decline in revenue for the first half reflects the resilience of our business model. During this period of focus on restructuring efforts, we view the revenue level achieved in H1 as a solid performance.' Update on Safeguard Procedure On July 10, 2025, Mauna Kea Technologies received court approval to initiate a "classes of affected parties" procedure, a framework introduced by the 2021 reform of France's business insolvency law. This process groups creditors into different classes to vote on a comprehensive restructuring plan. In this framework, Mauna Kea Technologies will present a plan in the coming weeks, aimed at significantly reducing its debt, to be submitted to the vote by the various creditor classes. As a reminder, the Company's current cash runway extends through November 2025. Discussions are underway, as part of this safeguard procedure, with strategic investors and family offices to secure long-term financing to support its sustainable development plan toward profitability. Key Highlights for the First Half 2025 U.S. Commercial Productivity U.S. Commercial Productivity 2021 2022 2023 2024 Q1 2025 Q2 2025 Revenue per sales rep (in $K) 1 281 551 629 626 832 913 Avg. number of sales reps (over the period) 17 8 8 6 4 6 Expand As of January 1 st, 2025, the U.S. sales team had 4 representatives, down from 8 at the beginning of 2024. Despite this reduction, the revenue increased significantly over the half year period. Since mid-2024, new initiatives have been implemented, both in terms of sales tactics in response to Medicare reimbursement cuts and sales organization effectiveness, with the promotion of two representatives to national leadership roles. These actions have led to a significant increase in per-rep productivity, reaching historic levels of around $800K to $900K in annual sales per representative. This positive momentum also supported the hiring of two new sales representatives during the first half of 2025, who quickly became operational. Pay-Per-Use (PPU) Procedure Volumes PPU procedure volume, which had gradually slowed in 2024 due to Medicare reimbursement cuts, has stabilized at over 800 procedures per quarter. At the end of Q2 2025, three new PPU accounts were signed, marking the first new contracts since Q3 2024. This recovery signals renewed commercial momentum and indicates potential for volume rebound. Furthermore, the Company is actively working toward a reimbursement reclassification, notably by correcting hospital-submitted reporting data and collaborating closely with physician associations and Medicare authorities. Revenue by Geography – H1 2025 By geography, business was mainly driven by the U.S., where the Company recorded a +14% growth as reported and +17% at constant currency (CC), with a dollar depreciation against the euro, especially in Q2 2025. This growth was primarily driven by system and probe sales, particularly in the pancreatic cysts indication, offsetting a decline in PPU revenue due to the gradual impact of lower Medicare reimbursement rates starting in 2024. In Europe, business activity was gradually impacted by the Company's financial context. However, this decline was almost entirely offset by strong performances in other regions. Revenue by Category – H1 2025 'We remain fully committed to ensuring that the safeguard procedure results in a situation that allows Mauna Kea Technologies to achieve financial stability. At the same time, we are actively structuring the financial resources necessary to execute our development plan, with the aim of transforming Mauna Kea into a Company that delivers both growth and profitability", concluded Sacha Loiseau. A ppendix - Details of Revenue for Q1 and Q2 2025 About Mauna Kea Technologies Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real time, classify indeterminate areas of concern, and guide surgical interventions. The Cellvizio® platform is used globally across a wide range of medical specialties and is making a transformative change in the way physicians diagnose and treat patients. For more information, visit Disclaimer This press release contains forward-looking statements about Mauna Kea Technologies and its business. All statements other than statements of historical fact included in this press release, including, but not limited to, statements regarding Mauna Kea Technologies' financial condition, business, strategies, plans and objectives for future operations are forward-looking statements. Mauna Kea Technologies believes that these forward-looking statements are based on reasonable assumptions. However, no assurance can be given that the expectations expressed in these forward-looking statements will be achieved. These forward-looking statements are subject to numerous risks and uncertainties, including those described in Chapter 2 of Mauna Kea Technologies' 2024 Annual Report filed with the Autorité des marchés financiers (AMF) on April 30, 2025, which is available on the Company's website ( as well as the risks associated with changes in economic conditions, financial markets and the markets in which Mauna Kea Technologies operates. The forward-looking statements contained in this press release are also subject to risks that are unknown to Mauna Kea Technologies or that Mauna Kea Technologies does not currently consider material. The occurrence of some or all of these risks could cause the actual results, financial condition, performance or achievements of Mauna Kea Technologies to differ materially from those expressed in the forward-looking statements. This press release and the information contained herein do not constitute an offer to sell or subscribe for, or the solicitation of an order to buy or subscribe for, shares of Mauna Kea Technologies in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The distribution of this press release may be restricted in certain jurisdictions by local law. Persons into whose possession this document comes are required to comply with all local regulations applicable to this document. 1 Annualized sales for the first and second quarters of 2025